On March 7, 2018 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM) ("Actinium" or "the Company"), reported that it will be attending and presenting at the 30th Annual ROTH Conference being held on March 11-14, 2018 at the Ritz Carlton in Dana Point, California (Press release, Actinium Pharmaceuticals, MAR 7, 2018, View Source [SID1234524477]). Details of Actinium’s presentation are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, March 13, 2018
Time: 11:00 AM PT
Room: Yellow – Salon 6
Venue: The Ritz Carlton Hotel

Management will conduct 1-on-1 meetings with investors during the conference. To arrange a meeting with Actinium please contact, Steve O’Loughlin, Actinium’s Principal Financial Officer at [email protected].

About 30th Annual ROTH Conference

30th Annual ROTH Conference scheduled for March 11-14, 2018 at The Ritz Carlton, Laguna Niguel in Orange County, CA. Following the success of the previous year’s events, the ROTH Conference, with close to 550 participating companies and over 4,700 attendees, will feature presentations from public and private companies in a variety of sectors including:

Business Services
Cleantech, Industrial Growth & Solar
Consumer
Healthcare
Resources: Oil & Gas / Metals & Mining
Technology, Internet & Media
This gathering of institutional investors, private equity investors, VCs and executives, and service providers has become a must-attend event for anyone working in the small and mid-cap space.